Abstract
This study was designed to compare the efficacy of selective laser trabeculoplasty (SLT) and micropulse laser trabeculoplasty (MLT) in patients with primary open angle glaucoma (POAG) requiring additional IOP control. In this retrospective, comparative study, we reviewed the charts of POAG patients requiring additional IOP lowering, who underwent either SLT or MLT and were followed for at least one year. We evaluated mean intraocular pressure (IOP), mean IOP reduction from baseline and mean number of glaucoma medications 1, 3, 6 and 12 months after treatment. Success rates (success defined as IOP ≤ 21 mmHg and ≥ 20% reduction from baseline IOP without additional medications, new laser session, or glaucoma surgery) at one year were also compared. A total of 98 POAG patients were included, 52 individuals in the SLT group and 46 in the MLT group. Laser treatment resulted in significant mean IOP reductions from baseline in both groups (SLT = -6.0 ± 3.3 mmHg (24.9%) and MLT = -5.8 ± 2.6 mmHg (23.4%)) (p < 0.001). However, there was no statistically significant difference between the mean IOP reductions in both groups (p = 0.74). At 12 months, the mean number of glaucoma medications was significantly smaller in the SLT group (1.17 + 0.4) when compared to the MLT group (2.21 + 0.2) (p = 0.001). Additionally, after 12 months, success was obtained in 32 (61.5%) SLT cases compared to 27 (58.7%) MLT-treated eyes (p = 1.0). MLT and SLT are both effective in controlling the IOP in POAG patients requiring additional IOP reduction. However, after 12 months, SLT demonstrated a greater efficacy in reducing medication burden when compared to MLT.
Trial registration: CEP/CONEP/MS Brazil 40948620.9.0000.5600
Similar content being viewed by others
Data availability
Upon reasonable request. De-identified participant data upon request to corresponding author.
References
Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267. https://doi.org/10.1136/bjo.2005.081224
Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, Suzuki K, White ET, Wormald RP, Xing W, Zeyen TG (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385(9975):1295–1304. https://doi.org/10.1016/S0140-6736(14)62111-5
Broadway DC, Grierson I, O’Brien C, Hitchings RA (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112(11):1446–54. https://doi.org/10.1001/archopht.1994.01090230060021
(1995) The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol 120(6):718–31. https://doi.org/10.1016/s0002-9394(14)72725-4
Latina MA, Park C (1995) Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Exp Eye Res 60(4):359–371. https://doi.org/10.1016/s0014-4835(05)80093-4
Latina MA, Sibayan SA, Shin DH, Noecker RJ, Marcellino G (1998) Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology 105(11):2082–8. https://doi.org/10.1016/S0161-6420(98)91129-0. (discussion 2089-90)
Katz LJ, Steinmann WC, Kabir A, Molineaux J, Wizov SS, Marcellino G, SLT/Med Study Group (2012) Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma 21(7):460–8. https://doi.org/10.1097/IJG.0b013e318218287f
Francis BA, Ianchulev T, Schofield JK, Minckler DS (2005) Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma. Am J Ophthalmol 140(3):524–525. https://doi.org/10.1016/j.ajo.2005.02.047
Garg A, Vickerstaff V, Nathwani N, Garway-Heath D, Konstantakopoulou E, Ambler G, Bunce C, Wormald R, Barton K, Gazzard G, Laser in Glaucoma and Ocular Hypertension Trial Study Group (2020) Efficacy of Repeat Selective laser trabeculoplasty in medication-naive open-angle glaucoma and ocular hypertension during the LiGHT trial. Ophthalmology 127(4):467–476. https://doi.org/10.1016/j.ophtha.2019.10.023
Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, Ambler G, Bunce C, Wormald R, Nathwani N, Barton K, Rubin G, Buszewicz M, LiGHT Trial Study Group (2019) Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 393(10180):1505–1516. https://doi.org/10.1016/S0140-6736(18)32213-X
Lee JWY, Yau GSK, Yick DWF, Yuen CYF (2015) MicroPulse laser trabeculoplasty for the treatment of open-angle glaucoma. Medicine (Baltimore) 94(49):e2075. https://doi.org/10.1097/MD.0000000000002075
Fudemberg SJ, Myers JS, Katz LJ (2008) Trabecular meshwork tissue examination with scanning electron microscopy: a comparison of micropulse diode laser (MLT), selective laser (SLT), and argon laser (ALT) trabeculoplasty in human cadaver tissue. Invest Ophthalmol Vis Sci 49:1236 (Presented at the ARVO annual meeting in 2008, Fort Lauderdale, FL, USA)
Detry-Morel M, Muschart F, Pourjavan S (2008) Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile. Bull Soc Belge Ophtalmol 308:21–28
Fea AM, Bosone A, Rolle T, Brogliatti B, Grignolo FM (2008) Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up. Clin Ophthalmol 2(2):247–252. https://doi.org/10.2147/opth.s2303
Rantala E, Välimäki J (2012) Micropulse diode laser trabeculoplasty – 180-degree treatment. Acta Ophthalmol 90(5):441–444. https://doi.org/10.1111/j.1755-3768.2010.02026.x
Babalola OE (2015) Micropulse diode laser trabeculoplasty in Nigerian patients. Clin Ophthalmol 20(9):1347–1351. https://doi.org/10.2147/OPTH.S82678.PMID:26229426;PMCID:PMC4516186
Abouhussein MA (2016) Micropulse laser trabeculoplasty for open- angle glaucoma. Delta J Ophthalmol 17:80e4
De Leon MI, Santana JFO, Lopex AG (2017) Selective laser trabeculoplasty vs micropulse laser trabeculoplasty for the treatment of open angle glaucoma and ocular hypertension. Int J Res Med Health Sci 14:1
Abramowitz B, Chadha N, Kouchouk A, Alhabshan R, Belyea DA, Lamba T (2018) Selective laser trabeculoplasty vs micropulse laser trabeculoplasty in open-angle glaucoma. Clin Ophthalmol 12:1599–1604. https://doi.org/10.2147/OPTH.S167102
Kakihara S, Hirano T, Imai A, Kurenuma T, Chiku Y, Murata T (2021) Micropulse laser trabeculoplasty under maximal tolerable glaucoma eyedrops: treatment effectiveness and impact of surgical expertise. Int J Ophthalmol 14(3):388–392. https://doi.org/10.18240/ijo.2021.03.09
Makri OE, Pallikari A, Pagoulatos D, Kagkelaris K, Kostopoulou EV, Georgakopoulos CD (2019) Micropulse laser trabeculoplasty on pseuodexfoliation glaucoma patients under topical prostaglandin analogue monotherapy: 1-year results. Graefes Arch Clin Exp Ophthalmol 257(2):349–355. https://doi.org/10.1007/s00417-018-4195-2
Hirabayashi MT, Rosenlof TL, An JA (2019) Comparison of successful outcome predictors for MicroPulse® laser trabeculoplasty and selective laser trabeculoplasty at 6 months. Clin Ophthalmol 13:1001–1009. https://doi.org/10.2147/OPTH.S205977
Hong Y, Song SJ, Liu B, Hassanpour K, Zhang C, Loewen N (2019) Efficacy and safety of micropulse laser trabeculoplasty for primary open angle glaucoma. Int J Ophthalmol 12(5):784–788. https://doi.org/10.18240/ijo.2019.05.13
Sun CQ, Chen TA, Deiner MS, Ou Y (2021) Clinical outcomes of micropulse laser trabeculoplasty compared to selective laser trabeculoplasty at one year in open-angle glaucoma. Clin Ophthalmol 15:243–251. https://doi.org/10.2147/OPTH.S285136
American Academy of Ophthalmology (2005) Primary Open-Angle Glaucoma: Preferred Practice Pattern. https://www.aao.org/preferred-practice-pattern/primary-open-angle-glaucoma-ppp-2015. Accessed 27 Feb 2019
Melamed S, Ben Simon GJ, Levkovitch-Verbin H (2003) Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 121(7):957–960. https://doi.org/10.1001/archopht.121.7.957
Ma A, Yu SWY, Wong JKW (2019) Micropulse laser for the treatment of glaucoma: A literature review. Surv Ophthalmol 64(4):486–497. https://doi.org/10.1016/j.survophthal.2019.01.001
L’Esperance FA Jr (1985) Clinical photocoagulation with the organic dye laser. A preliminary communication. Arch Ophthalmol 103(9):1312–1316. https://doi.org/10.1001/archopht.1985.01050090064033
Mainster MA (1986) Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology 93(7):952–8. https://doi.org/10.1016/s0161-6420(86)33637-6
Birt CM (2007) Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Can J Ophthalmol 42(5):715–719. https://doi.org/10.3129/i07-131
Weinand FS, Althen F (2006) Long-term clinical results of selective laser trabeculoplasty in the treatment of primary open angle glaucoma. Eur J Ophthalmol 16(1):100–104. https://doi.org/10.1177/112067210601600116
McIlraith I, Strasfeld M, Colev G, Hutnik CM (2006) Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma 15(2):124–130. https://doi.org/10.1097/00061198-200604000-00009
Rosenfeld E, Shemesh G, Kurtz S (2012) The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients. Clin Ophthalmol 6:1935–1940. https://doi.org/10.2147/OPTH.S34193
Nagar M, Ogunyomade A, O’Brart DP, Howes F, Marshall J (2005) A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol 89(11):1413–1417. https://doi.org/10.1136/bjo.2004.052795
Juzych MS, Chopra V, Banitt MR, Hughes BA, Kim C, Goulas MT, Shin DH (2004) Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology 111(10):1853–1859. https://doi.org/10.1016/j.ophtha.2004.04.030
Author information
Authors and Affiliations
Contributions
RLP obtained funding. Study, Design: RLP, DL, VPC. Patient recruitment: WL, RR, WL. Laser application: RLP. Data collection WL, RR, DL. Data analysis: DL, RR, VPC. Drafting manuscript: RL, RR, VPC.
Corresponding author
Ethics declarations
Ethics approval
CEP/CONEP 40948620.9.0000.5600.
Informed consent
Patient consent for publication was not required.
Competing interests
The authors have no competing interests to declare that are relevant to the content of this article.
Universal Trial Number (UTN)
U1111-1267–2146
Trial registration
Brazilian Clinical Trials Registry (ReBec) #11403.
Provenance and peer review
Not commissioned; externally peer reviewed.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pimentel, R.L., Alves Júnior, R.R., Lima, W.M.M.L. et al. Selective laser trabeculoplasty versus micropulse laser trabeculoplasty for intraocular pressure control in patients with primary open angle glaucoma: a 12-month retrospective comparative study. Lasers Med Sci 38, 102 (2023). https://doi.org/10.1007/s10103-023-03771-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10103-023-03771-9